Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.

Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out ...

Another great remedy that works for both sensitive and non-sensitive teeth is brushing with a purple toothpaste. The paste's ...

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15 ...

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...

From Tesla's persisting problems to Formula One and LVMH's latest 10-year long tie-up, here's a look at some of the major ...

Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...